Back to Journals » OncoTargets and Therapy » Volume 14

Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy

Total article views   HTML views PDF downloads Totals
5,671 Dovepress* 4,835+ 610 5,445
PubMed Central* 836 315 1,151
Totals 5,671 925 6,596
*Since 2 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
19 0 0 0 9 10

View citations on PubMed Central and Google Scholar